Etonogestrel and ethinyl estradiol and Norgestimate and ethinyl estradiol interaction

Etonogestrel and ethinyl estradiol and Norgestimate and ethinyl estradiol: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Etonogestrel and ethinyl estradiol (Etonogestrel/Ethinyl Estradiol) label · effective 2025-02-26

Major

WARNING: CIGARETTE SMOKING AND SERIOUS CARDIOVASCULAR EVENTS Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive (CHC) use.

Boxed warningby drug classView label on DailyMed
Major

Cigarette smoking increases the risk of serious cardiovascular events from combination hormonal contraceptive (CHC) use.

Boxed warningby drug classView label on DailyMed
Moderate

Effects of CHCs on Other Drugs CHCs containing ethinyl estradiol may inhibit the metabolism of other compounds (e.g., cyclosporine, prednisolone, theophylline, tizanidine, and voriconazole) and increase their plasma concentrations.

Drug interactionsnames Norgestimate and ethinyl estradiolView label on DailyMed
Moderate

Consider an alternate contraceptive method for women with uncontrolled dyslipidemia.

Warnings and precautionsby drug classView label on DailyMed
Moderate

In these studies, which were required or sponsored by regulatory agencies, Etonogestrel/Ethinyl Estradiol Vaginal Ring users had a risk of VTE similar to Combined Oral Contraceptives (COCs) users (see Table 1 for adjusted hazard ratios).

Warnings and precautionsby drug classView label on DailyMed

From the Norgestimate and ethinyl estradiol (MONO-LINYAH) label · effective 2026-06-23

Moderate

Effects of Other Drugs on Combined Oral Contraceptives Substances decreasing the plasma concentrations of COCs Drugs or herbal products that induce certain enzymes, including cytochrome P450 3A4 (CYP3A4), may decrease the plasma concentrations of COCs and potentially diminish the effectiveness of COCs or increase breakthrough bleeding.

Drug interactionsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.